Christopher J. Woolverton is Professor of Epidemiology, Dean's Fellow to the University Health Services, and Chair of the Institutional Biosafety Committee, at Kent State University. He additionally serves on the faculty of the NIH National Biosafety and Biosecurity Training Program, and on the graduate faculty of the Northeastern Ohio Universities College of Medicine. Woolverton earned the M.S. and Ph.D. in Medical Microbiology from West Virginia University's School of Medicine. He also has advanced training in laboratory containment practices, biological safety, international biosecurity, pandemic planning, control of biohazards, and biosecurity policy analysis. Woolverton's research is focused on the detection and control of infectious agents. He has published on the development of a liquid crystal biosensor, for the real-time identification of bacteria and virus; the identification of microbial proteins, whose biological function is driven by their liquid crystalline properties; the use of electron beam energy for the control of Bacillus spores; the use of nonthermal plasma for the control of bacterial biofilms; the use of medium-chain fatty acids to control Clostridium spores; the use of Twitter and survey data to detect undergraduate student perceived risk of Ebola and SARS-CoV-2, respectively; and the use of human fibrin as a long-term, antibiotic delivery system. Woolverton also co-authored four editions of the undergraduate microbiology textbook, Prescott’s Microbiology (editions 7-10) and on the use of the NIH Designated Training Facility (BSL-3 Sim Lab) to document learning behaviors in high stress environments.
State Department Profile
Under Secretary for Management Medical Services Bureau
Christopher Woolverton serves as a Program Analyst in the Occupational Health and Wellness (OHW) office within the Medical Services Bureau (MED). MED's mission is to safeguard and promote the health and well-being of America's diplomatic community. MED develops and implements medical policies for the Department and advises the Secretary on global healthcare issues. The Bureau's mission is accomplished via a central staff in Washington, DC that supports the delivery of quality healthcare by medical professionals and health unit personnel at missions worldwide. Dr. Woolverton is sharing with MED the COVID response developed at his university, as an example of pandemic response at U.S. institutions of higher education. Additionally, he is collaborating on a variety of projects relating to human health and wellness domestically and at U.S. embassies and consulates around the globe. In this role, he is working with air pollution scientists, industrial hygienists, laboratorians, nurses, and physicians to support responses to (1) the impacts of air pollution in respiratory disease, (2) workplace hazards, and (3) the COVID-19 pandemic.
|